Armetheon Closes $24 Million Series B Financing

Dr. Larry Hsu Elected to Board of Directors Menlo Park, CA – February 5, 2015 – Armetheon, Inc., a cardiovascular disease-focused, clinical stage, specialty biopharmaceutical company, today announced the successful closing of $24.3 million in Series B financing. The...